Fairmount
Funding rounds backed by Fairmount.
- Funding disclosed in full
- $425M
- Median round
- $212.5M
- Rounds in calculation
- 2
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Korsana Biosciences Develops novel therapies to reduce the burden of neurodegenerative diseases | $175MSeries A | BiotechUnited States | |||
| Mirador Therapeutics Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases | $250MSeries B | BiotechUnited States | 17 participantsAdage Capital Partners L.P.ARCH Venture PartnersBlue Owl Healthcare OpportunitiesBoxer CapitalFairmountFarallon Capital ManagementFidelity Management & Research CompanyInc.InvusLogos CapitalMoore Strategic VenturesOrbiMedPoint72TCGXT. Rowe Price Investment ManagementVenrock Healthcare Capital PartnersWoodline Partners LP |